What Can We Expect from Buccal Drug Delivery System Market Size and Growth Rates?
The buccal drug delivery system market size has seen robust growth, increasing from $3.55 billion in 2024 to $3.91 billion in 2025 at a compound annual growth rate (CAGR) of 10.3%. This impressive growth is attributed to early drug delivery innovations, pharmaceutical industry adoption, clinical studies, market penetration strategies, and disease-specific applications.
The buccal drug delivery system market size is expected to surge in the coming years, growing to $5.97 billion in 2029 at a compound annual growth rate (CAGR) of 11.1%. This predicted growth stems from factors such as patient-centric drug delivery, a rising geriatric population, demand for targeted therapies, biologics and peptides delivery, regulatory support, approvals, and investments in R&D. Trends expected to drive the market include patient convenience and compliance, advancements in drug formulations, a rise in chronic diseases, and enhanced bioavailability.
Get Your Free Sample of The Global Buccal Drug Delivery System Market Report: https://www.thebusinessresearchcompany.com/sample.aspx?id=8290&type=smp
What Are The Key Growth Drivers for the Buccal Drug Delivery Systems Market?
Growth in the buccal drug delivery system market is being driven by the rising prevalence of chronic diseases such as cancer, heart disease, stroke, diabetes, and arthritis. These ailments require consistent medical care and nutrition, and buccal drug delivery systems provide an effective method for administering mucosal and transmucosal drugs. For instances, as per the World Health Organisation report, in September 2023, non-communicable diseases (NCDs) or chronic diseases were accountable for 74% of all global deaths, highlighting the growing necessity for buccal drug delivery systems.
Which Are the Major Segments Within the Global Buccal Drug Delivery System Market?
1) By Type: Sublingual, Buccal Tablets And Lozenges, Oral Sprays
2) By Application: Pain Management, Smoking Cessation, Angina Pectoris
3) By End-User: Hospitals, Ambulatory Centers, Other End-Users
Order your report now for swift delivery: https://www.thebusinessresearchcompany.com/report/buccal-drug-delivery-system-global-market-report
Who Are The Major Players in the Buccal Drug Delivery System Market?
Key players operating in the buccal drug delivery system market include Teva Pharmaceuticals Industries Ltd., Pfizer Incorporated, GlaxoSmithKline Public Limited Company, Indivior PLC, Generex Biotechnology Corporation, Catalent Inc., and, BioDelivery Science International Incorporated among others.
What Trends Are Emerging within The Buccal Drug Delivery Systems Market?
One emerging trend within the buccal drug delivery system market is the focus of major players on developing innovative solutions for improving patient outcomes and enhancing drug delivery efficacy. One such example is the oral treatment for plaque psoriasis, a chronic autoimmune condition. In September 2022, Bristol Myers Squibb received FDA approval for Sotyktu (deucravacitinib), the first new oral therapy for adults with moderate-to-severe plaque psoriasis in nearly a decade.
What Does The Regional Analysis of The Buccal Drug Delivery System Market Indicate?
In 2024, North America held the largest share in the buccal drug delivery systems market. Other key regions reflected in the report are Asia-Pacific, Western Europe, Eastern Europe, South America, Middle East, and Africa.
What Does The Buccal Drug Delivery System Market Report 2025 Offer?
The buccal drug delivery system refers to the administration of medications through the buccal mucosal membrane lining of the mouth cavity. This technique is effective for delivering mucosal and transmucosal drugs. The Buccal Drug Delivery System Market research report from The Business Research Company offers global market size, growth rate, regional shares, competitor analysis, detailed segments, trends, and opportunities.
Purchase the exclusive report now to unlock valuable market insights: https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=8290
About The Business Research Company:
The Business Research Company is a trusted source for market intelligence, with over 15000+ reports from 27 industries covering 60+ geographies. We offer comprehensive, data-rich research and insights, supported by 1,500,000 datasets, in-depth secondary research, and unique industry leader inputs, to help you stay ahead.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
